Chinese Firms Ordered To Pay Pfizer Unit $57.5 Million In Spy Case
This article was originally published in PharmAsia News
A county judge in North Carolina ruled in favor of the state's Serenex biopharmaceutical company in a suit against China's Beijing Gylongli Science and Technology and GYLL Biomedtech. The Serenex suit said the people from the two companies engaged in corporate espionage against the U.S. firm and stole trade secrets. A Wake County judge ordered the Chinese companies and Tongxiang Zhang, operator of both companies, to pay Serenex $57.5 million in damages. Serenex, acquired by Pfizer earlier this year, sued after Zhang and others applied for a patent for a drug similar to the Serenex drug. None of the Chinese parties to the suit responded legally to the filing of the suit. (Click here for more
You may also be interested in...
Demand for tele-diagnostic tools has reached unprecedented levels during COVID-19, said Kees Wesdrop, Royal Philips’ chief business leader of precision diagnosis.
Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue
Former acting Commissioner Josh Sharfstein argues that while agency officials have done a commendable job in overall communication on COVID vaccine development, more information is needed on the clinical holds.
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.